These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 17548083

  • 1. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
    Lee JR, Choi YS, Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH.
    Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
    [Abstract] [Full Text] [Related]

  • 2. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles.
    Hill MJ, Miller KA, Frattarelli JL.
    Fertil Steril; 2010 Feb; 93(2):416-22. PubMed ID: 19171338
    [Abstract] [Full Text] [Related]

  • 3. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [Abstract] [Full Text] [Related]

  • 4. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I, Stein DE, Keltz MD.
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [Abstract] [Full Text] [Related]

  • 5. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P.
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [Abstract] [Full Text] [Related]

  • 6. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [Abstract] [Full Text] [Related]

  • 7. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A.
    Hum Reprod; 2017 Mar 01; 32(3):556-567. PubMed ID: 28130435
    [Abstract] [Full Text] [Related]

  • 8. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study.
    Gelbaya TA, Nardo LG, Hunter HR, Fitzgerald CT, Horne G, Pease EE, Brison DR, Lieberman BA.
    Fertil Steril; 2006 Mar 01; 85(3):603-9. PubMed ID: 16500326
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul 01; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 10. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May 01; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 11. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony.
    Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R.
    Fertil Steril; 2008 Jan 01; 89(1):20-6. PubMed ID: 17224151
    [Abstract] [Full Text] [Related]

  • 12. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
    Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A.
    Hum Reprod; 2007 May 01; 22(5):1348-52. PubMed ID: 17303632
    [Abstract] [Full Text] [Related]

  • 13. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov 01; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 14. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C.
    Fertil Steril; 2009 Jul 01; 92(1):226-30. PubMed ID: 18675961
    [Abstract] [Full Text] [Related]

  • 15. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb 01; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 16. Effect of coasting on the implantation potential of embryos transferred after cryopreservation and thawing.
    Arslan M, Bocca S, Jones E, Mayer J, Stadtmauer L, Oehninger S.
    Fertil Steril; 2005 Oct 01; 84(4):867-74. PubMed ID: 16213837
    [Abstract] [Full Text] [Related]

  • 17. Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2-3 embryo transfer cycles: a prospective, randomized study.
    Levitas E, Lunenfeld E, Har-Vardi I, Albotiano S, Sonin Y, Hackmon-Ram R, Potashnik G.
    Fertil Steril; 2004 Mar 01; 81(3):567-71. PubMed ID: 15037404
    [Abstract] [Full Text] [Related]

  • 18. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.
    Fertil Steril; 2009 Feb 01; 91(2):377-82. PubMed ID: 18321490
    [Abstract] [Full Text] [Related]

  • 19. Cryopreserved embryo transfers suggest that endometrial receptivity may contribute to reduced success rates of later developing embryos.
    Richter KS, Shipley SK, McVearry I, Tucker MJ, Widra EA.
    Fertil Steril; 2006 Oct 01; 86(4):862-6. PubMed ID: 16935284
    [Abstract] [Full Text] [Related]

  • 20. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.
    Fertil Steril; 2013 May 01; 99(6):1644-53. PubMed ID: 23394782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.